Navigation Links
EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health
Date:6/18/2009

VIENNA, Austria, and CUXHAVEN, Germany, June 18 /PRNewswire/ -- EUCODIS Bioscience, a company developing, manufacturing, and marketing enzymes and other proteins for the chemical industry, announced today that it has achieved an important milestone in the development of an undisclosed protein for Lohmann Animal Health (LAH), a leading provider of feed components and vaccines for farm animals. This achievement triggered a milestone payment from LAH to EUCODIS Bioscience.

EUCODIS Bioscience is developing an innovative protein that LAH plans to use as the active ingredient of a new product line. EUCODIS Bioscience and LAH currently have two development agreements in place. In February, EUCODIS Bioscience announced the achievement of a development milestone pertaining to a separate agreement with LAH.

"We have made significant progress in developing a protein showing innovative properties that will bring significant value for agricultural applications," said Rudy Pandjaitan, PhD, CEO of EUCODIS Bioscience. "We are excited about this project, as the product we are developing for our partner LAH has the potential to open a new market in the food and feed industry."

About EUCODIS Bioscience

EUCODIS Bioscience GmbH develops, manufactures, and markets industrial enzymes.

EUCODIS Bioscience' products help customers in the chemical, pharmaceutical, and food and feed industries to make manufacturing processes more efficient and cleaner, and to generate products with superior properties.

EUCODIS Bioscience originally focused on developing enzymes for industrial partners, including GlaxoSmithKline, Henkel, and Lohmann Animal Health. Since 2009, the Company also markets its own products.

Led by an experienced management team, EUCODIS Bioscience is backed by Austrian and German institutional venture capital funds, founders, and private investors. The Com
'/>"/>

SOURCE EUCODIS Bioscience
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015   Regulus ... biopharmaceutical company leading the discovery and development of ... Kleanthis G. Xanthopoulos , Ph.D. has resigned as ... member of Regulus, Board of Directors, effective today, ...  Paul Grint, M.D., who previously served as Chief ...
(Date:6/1/2015)... The nuclear imaging market is estimated to grow to ... Nuclear medicine is the use of radioisotopes for the ... imaging used commonly are PET and SPECT. Till recently, ... applications like nuclear cardiology procedures. However, the trend is ... molybdenum-99 isotope which is in turn will lead to ...
(Date:6/1/2015)... DURHAM, N.C. , June 1, 2015  bioMérieux, ... vitro diagnostics, has been invited to join the ... of antibiotic use in the U.S. as a means ... various sectors, will gather tomorrow, June 2, 2015, to ... next five years to slow the emergence of antibiotic-resistant ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 2North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 3bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3
... Conference on Avian,Influenza at France's Pasteur Institute, PARIS, ... of,Novavax Inc.'s pandemic influenza vaccine provided protection,against a ... data presented here today at the Second International,Conference ... show that two 0.6 microgram doses of Novavax's,virus-like ...
... of Rare but Devastating,Condition , LONDON, June 1, ... of Leicester and have today (Friday June 1),announced ... rare but,devastating medical condition that can affect children ... clinicians and scientists from the two,universities have already ...
Cached Medicine Technology:Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 2Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 3Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 2World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 3World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 5
(Date:6/2/2015)... TheCelebrityDresses.com, a popular online store selling celebrity ... summer fashion cocktail dresses. The company carries more than ... be suitable for a wide variety of summer events ... and make high quality trendy special occasion dresses ... quality satin, chiffon and cotton. Their products feature a ...
(Date:6/2/2015)... 2015 Consumer Reports, the world’s ... announced its commitment to help wipe out antibiotic-resistant ... of antibiotics sicken about 2.25 million Americans each ... for Disease Control and Prevention. , The initiative ... Marta Tellado participating in the White House Forum ...
(Date:6/2/2015)... 2015 Amercanex, the American Cannabis ... to become Amercanex’s new Chief Technology Officer. Amercanex ... which cultivators, wholesale distributors and retail vendors can ... fully transparent intra-state market. , Jim Miller is ... technology space, helping innovative technology companies deliver on ...
(Date:6/2/2015)... Colleen’s Dream Foundation , with fundraising help from ... to support ovarian cancer research conducted by Cheng Wang, Ph.D. ... Colleen’s Dream Foundation Board of Directors. , Cundiff says the ... Colleen’s Dream Foundation and they couldn’t have picked a better ... a rising star in the ovarian cancer world,” says Cundiff. ...
(Date:6/2/2015)... 2015 Each year, Cosmetic Executive Women ... Awards. This year, the organization’s members – 8,000 industry ... the QVC® Beauty Quest Award at the 2015 Beauty ... (ME) Technology and 2-in-1 approach to skincare differentiated it ... brand’s loyal consumer and professional fan bases, QVC has ...
Breaking Medicine News(10 mins):Health News:Consumer Reports Aims to Stop the Spread of Superbugs 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 3Health News:Amercanex Names Jim Miller to CTO Position 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 3Health News:Scalisi Skincare Wins Coveted CEW QVC Beauty Quest Award for Innovative and Patented Formulation 2
... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announces the following webcast:, ... conjunction with the 2009 ... corporate update will be presented by Stanley T. Crooke, M.D., ... Executive Officer of Isis., When: Tuesday, June 2, 2009, ...
... VIDEO ALERT: Additional audio and video resources, including excerpts ... the research, are available on the Mayo Clinic ... Mayo Clinic compared two popular television shows, CSI and ... clear differences between media portrayals of violent deaths versus ...
... Health Care CostsHARRISBURG, Pa., May 19 A budget ... or eliminate vital access to health care and services ... Everette James warned today."In today,s economic climate, access to ... Pennsylvanians. The Department of Health,s programs to expand access ...
... May 19 Boston Scientific Corporation (NYSE: BSX ... rating outlook to positive from stable, while affirming the Company,s ... reflects:, , ... its drug-eluting stent (DES) business and returning its cardiac rhythm ...
... Study Highlights the Clinical Success of Dental Implants ... 19 BioHorizons, a leader in the dental ... three-year prospective, controlled, multi-center study of implants with ... observed for Laser-Lok in vitro and ...
... in the womb , , TUESDAY, May 19 (HealthDay News) ... to become a regular smoker as a teen and ... University of Arizona researchers. , "Somehow smoke is changing ... Grad, an associate professor of clinical pediatrics at the ...
Cached Medicine News:Health News:Webcast Alert: Isis Pharmaceuticals To Provide General Corporate Update in Conjunction with 2009 Annual Meeting of Stockholders 2Health News:CSI: Mayo Clinic Researchers Find Television Shows Inaccurately Portray Violent Crime 2Health News:Senate's Proposed Budget Threatens the Health of Millions of Pennsylvanians 2Health News:Fitch Raises Boston Scientific's Rating Outlook to Positive 2Health News:Fitch Raises Boston Scientific's Rating Outlook to Positive 3Health News:BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels 2Health News:BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels 3Health News:Kids More Apt to Smoke If Mom Did While Pregnant 2Health News:Kids More Apt to Smoke If Mom Did While Pregnant 3
... C spins up to 25,000 x g for quick ... and ease of use. The Model 5417 C is ... a cold room and can accommodate a variety of ... , Spin up to 16,400 rpm; 25,000 x ...
... laboratory floor model centrifuge meets UL and ... suitable for use in Class 1, Group ... gasoline, petroleum, naphtha, benzol, lacquer, solvent vapors ... is so strict that the EXD design ...
... Hybridization Oven/Shaker rigidly controls the temperature ... of hybridization and washing steps. This ... of nucleic acids and proteins immobilized ... with radioactive and nonradioactive labeling systems ...
... Oven with circular clear acrylic chamber for ... HybriCycler Oven features microprocessor operation for precise ... the unit., Carousel rotates at 11 ... ,easily removable , Bottle Capacity - ...
Medicine Products: